Scientists test 'Double-Edged' gene therapy to fight HIV and cancer
NCT ID NCT02337985
Summary
This early-stage study is testing a two-part treatment for AIDS patients who also have a type of blood cancer called non-Hodgkin lymphoma. First, patients receive standard chemotherapy to fight the cancer. Then, doctors collect the patient's own blood stem cells, modify them in a lab to carry genes that may help block HIV, and return them to the patient. The main goal is to see if this combined approach is safe and possible, and if the modified cells can survive and potentially help the body control both diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NCI Lymphoid Malignancies Branch
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.